Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in Int J Oncol

Retrieve available abstracts of 68 articles:
HTML format
Text format



Single Articles


    February 2017
  1. PANAGOPOULOS V, Leach DA, Zinonos I, Ponomarev V, et al
    Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment.
    Int J Oncol. 2017 Feb 20. doi: 10.3892/ijo.2017.3883.
    PubMed     Text format     Abstract available


  2. LANGO-CHAVARRIA M, Chimal-Ramirez GK, Ruiz-Tachiquin ME, Espinoza-Sanchez NA, et al
    A 22q11.2 amplification in the region encoding microRNA-650 correlates with the epithelial to mesenchymal transition in breast cancer primary cultures of Mexican patients.
    Int J Oncol. 2017;50:432-440.
    PubMed     Text format     Abstract available


  3. GUERRIERO E, Sorice A, Capone F, Storti G, et al
    Combining doxorubicin with a phenolic extract from flaxseed oil: Evaluation of the effect on two breast cancer cell lines.
    Int J Oncol. 2017;50:468-476.
    PubMed     Text format     Abstract available


    January 2017
  4. TRIANTAFILLU UL, Park S, Klaassen NL, Raddatz AD, et al
    Fluid shear stress induces cancer stem cell-like phenotype in MCF7 breast cancer cell line without inducing epithelial to mesenchymal transition.
    Int J Oncol. 2017 Jan 30. doi: 10.3892/ijo.2017.3865.
    PubMed     Text format     Abstract available


  5. JIANG W, Li X, Li T, Wang H, et al
    Repositioning of amprenavir as a novel extracellular signal-regulated kinase-2 inhibitor and apoptosis inducer in MCF-7 human breast cancer.
    Int J Oncol. 2017 Jan 24. doi: 10.3892/ijo.2017.3860.
    PubMed     Text format     Abstract available


    December 2016
  6. MAXWELL T, Chun SY, Lee KS, Kim S, et al
    The anti-metastatic effects of the phytoestrogen arctigenin on human breast cancer cell lines regardless of the status of ER expression.
    Int J Oncol. 2016 Dec 29. doi: 10.3892/ijo.2016.3825.
    PubMed     Text format     Abstract available


  7. NAKAYAMA J, Ito E, Fujimoto J, Watanabe S, et al
    Comparative analysis of gene regulatory networks of highly metastatic breast cancer cells established by orthotopic transplantation and intra-circulation injection.
    Int J Oncol. 2016 Dec 16. doi: 10.3892/ijo.2016.3809.
    PubMed     Text format     Abstract available


  8. PARK JH, Kim HK, Jung H, Kim KH, et al
    NecroX-5 prevents breast cancer metastasis by AKT inhibition via reducing intracellular calcium levels.
    Int J Oncol. 2016 Dec 5. doi: 10.3892/ijo.2016.3789.
    PubMed     Text format     Abstract available


    November 2016
  9. SHYAMASUNDAR S, Lim JP, Bay BH
    miR-93 inhibits the invasive potential of triple-negative breast cancer cells in vitro via protein kinase WNK1.
    Int J Oncol. 2016 Nov 7. doi: 10.3892/ijo.2016.3761.
    PubMed     Text format     Abstract available


  10. GOMULKIEWICZ A, Jablonska K, Pula B, Grzegrzolka J, et al
    Expression of metallothionein 3 in ductal breast cancer.
    Int J Oncol. 2016 Nov 4. doi: 10.3892/ijo.2016.3759.
    PubMed     Text format     Abstract available


    October 2016
  11. ZHOU H, Li J, Zhang Z, Ye R, et al
    RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
    Int J Oncol. 2016 Oct 5. doi: 10.3892/ijo.2016.3718.
    PubMed     Text format     Abstract available


    September 2016
  12. MEJIA-RANGEL J, Cordova E, Orozco L, Ventura-Gallegos JL, et al
    Pro-adhesive phenotype of normal endothelial cells responding to metastatic breast cancer cell conditioned medium is linked to NFkappaB-mediated transcriptomic regulation.
    Int J Oncol. 2016 Sep 26. doi: 10.3892/ijo.2016.3705.
    PubMed     Text format     Abstract available


  13. DING J, Guo C, Hu P, Chen J, et al
    CSF1 is involved in breast cancer progression through inducing monocyte differentiation and homing.
    Int J Oncol. 2016 Sep 6. doi: 10.3892/ijo.2016.3680.
    PubMed     Text format     Abstract available


  14. LIU ZG, Tang J, Chen Z, Zhang H, et al
    The novel mTORC1/2 dual inhibitor INK128 enhances radiosensitivity of breast cancer cell line MCF-7.
    Int J Oncol. 2016;49:1039-45.
    PubMed     Text format     Abstract available


  15. ZHAO Q, Zhao M, Parris AB, Xing Y, et al
    Genistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells.
    Int J Oncol. 2016;49:1203-10.
    PubMed     Text format     Abstract available


  16. PARK JH, Cho YY, Yoon SW, Park B, et al
    Suppression of MMP-9 and FAK expression by pomolic acid via blocking of NF-kappaB/ERK/mTOR signaling pathways in growth factor-stimulated human breast cancer cells.
    Int J Oncol. 2016;49:1230-40.
    PubMed     Text format     Abstract available


  17. GALLARDO M, Calaf GM
    Curcumin inhibits invasive capabilities through epithelial mesenchymal transition in breast cancer cell lines.
    Int J Oncol. 2016;49:1019-27.
    PubMed     Text format     Abstract available


  18. IBRAHIM T, Liverani C, Mercatali L, Sacanna E, et al
    [Corrigendum] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines.
    Int J Oncol. 2016;49:1260.
    PubMed     Text format     Abstract available


  19. CHA J, Roomi MW, Kalinovsky T, Niedzwiecki A, et al
    Lipoprotein(a) and vitamin C impair development of breast cancer tumors in Lp(a)+; Gulo-/- mice.
    Int J Oncol. 2016;49:895-902.
    PubMed     Text format     Abstract available


  20. PARK HJ, Kim MK, Choi KS, Jeong JW, et al
    Neuromedin B receptor antagonism inhibits migration, invasion, and epithelial-mesenchymal transition of breast cancer cells.
    Int J Oncol. 2016;49:934-42.
    PubMed     Text format     Abstract available


    August 2016
  21. MIYAHARA K, Kazama H, Kokuba H, Komatsu S, et al
    Targeting bortezomib-induced aggresome formation using vinorelbine enhances the cytotoxic effect along with ER stress loading in breast cancer cell lines.
    Int J Oncol. 2016 Aug 29. doi: 10.3892/ijo.2016.3673.
    PubMed     Text format     Abstract available


  22. HE DX, Zhang GY, Gu XT, Mao AQ, et al
    Genome-wide profiling of long non-coding RNA expression patterns in anthracycline-resistant breast cancer cells.
    Int J Oncol. 2016 Aug 22. doi: 10.3892/ijo.2016.3665.
    PubMed     Text format     Abstract available


  23. KARIYA Y, Tatsuta T, Sugawara S, Kariya Y, et al
    RNase activity of sialic acid-binding lectin from bullfrog eggs drives antitumor effect via the activation of p38 MAPK to caspase-3/7 signaling pathway in human breast cancer cells.
    Int J Oncol. 2016 Aug 11. doi: 10.3892/ijo.2016.3656.
    PubMed     Text format     Abstract available


  24. CHOI YJ, Heo K, Park HS, Yang KM, et al
    The resveratrol analog HS-1793 enhances radiosensitivity of mouse-derived breast cancer cells under hypoxic conditions.
    Int J Oncol. 2016 Aug 3. doi: 10.3892/ijo.2016.3647.
    PubMed     Text format     Abstract available


    July 2016
  25. XU H, Wu K, Tian Y, Liu Q, et al
    CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer.
    Int J Oncol. 2016 Jul 29. doi: 10.3892/ijo.2016.3639.
    PubMed     Text format     Abstract available


  26. SULAIMAN NB, Mohan CD, Basappa S, Pandey V, et al
    An azaspirane derivative suppresses growth and induces apoptosis of ER-positive and ER-negative breast cancer cells through the modulation of JAK2/STAT3 signaling pathway.
    Int J Oncol. 2016 Jul 6. doi: 10.3892/ijo.2016.3615.
    PubMed     Text format     Abstract available


    June 2016
  27. KIM B, Kim YC, Park B
    Pomolic acid inhibits metastasis of HER2 overexpressing breast cancer cells through inactivation of the ERK pathway.
    Int J Oncol. 2016 Jun 7. doi: 10.3892/ijo.2016.3568.
    PubMed     Text format     Abstract available


  28. PILCO-FERRETO N, Calaf GM
    Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines.
    Int J Oncol. 2016 Jun 3. doi: 10.3892/ijo.2016.3558.
    PubMed     Text format     Abstract available


    May 2016
  29. PARK JH, Jang M, Tarhan YE, Katagiri T, et al
    Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy.
    Int J Oncol. 2016 May 27. doi: 10.3892/ijo.2016.3540.
    PubMed     Text format     Abstract available


  30. YAMAGUCHI M, Osuka S, Weitzmann MN, Shoji M, et al
    Increased regucalcin gene expression extends survival in breast cancer patients: Overexpression of regucalcin suppresses the proliferation and metastatic bone activity in MDA-MB-231 human breast cancer cells in vitro.
    Int J Oncol. 2016 May 24. doi: 10.3892/ijo.2016.3538.
    PubMed     Text format     Abstract available


  31. MENG X, Hu B, Hossain MM, Chen G, et al
    ADAM17-siRNA inhibits MCF-7 breast cancer through EGFR-PI3K-AKT activation.
    Int J Oncol. 2016 May 24. doi: 10.3892/ijo.2016.3536.
    PubMed     Text format     Abstract available


  32. CHEN SY, Zheng XW, Cai JX, Zhang WP, et al
    Histone deacetylase inhibitor reverses multidrug resistance by attenuating the nucleophosmin level through PI3K/Akt pathway in breast cancer.
    Int J Oncol. 2016 May 17. doi: 10.3892/ijo.2016.3528.
    PubMed     Text format     Abstract available


  33. WOODMAN N, Pinder SE, Tajadura V, Le Bourhis X, et al
    Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer.
    Int J Oncol. 2016 May 13. doi: 10.3892/ijo.2016.3521.
    PubMed     Text format     Abstract available


  34. KWON YS, Lee KS, Chun SY, Jang TJ, et al
    Suppressive effects of a proton beam on tumor growth and lung metastasis through the inhibition of metastatic gene expression in 4T1 orthotopic breast cancer model.
    Int J Oncol. 2016 May 13. doi: 10.3892/ijo.2016.3520.
    PubMed     Text format     Abstract available


  35. GARCIA EP, Tiscornia I, Libisch G, Trajtenberg F, et al
    MUC5B silencing reduces chemo-resistance of MCF-7 breast tumor cells and impairs maturation of dendritic cells.
    Int J Oncol. 2016;48:2113-23.
    PubMed     Text format     Abstract available


    April 2016
  36. LAURICELLA M, Carlisi D, Giuliano M, Calvaruso G, et al
    The analysis of estrogen receptor-alpha positive breast cancer stem-like cells unveils a high expression of the serpin proteinase inhibitor PI-9: Possible regulatory mechanisms.
    Int J Oncol. 2016 Apr 21. doi: 10.3892/ijo.2016.3495.
    PubMed     Text format     Abstract available


  37. KIM MH, Kim MH, Kim KS, Park MJ, et al
    In vivo monitoring of CD44+ cancer stem-like cells by gamma-irradiation in breast cancer.
    Int J Oncol. 2016 Apr 18. doi: 10.3892/ijo.2016.3493.
    PubMed     Text format     Abstract available


  38. GRUNDKER C, Bauerschmitz G, Schubert A, Emons G, et al
    Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH.
    Int J Oncol. 2016 Apr 18. doi: 10.3892/ijo.2016.3491.
    PubMed     Text format     Abstract available


  39. LI K, Wei L, Huang Y, Wu Y, et al
    Leptin promotes breast cancer cell migration and invasion via IL-18 expression and secretion.
    Int J Oncol. 2016 Apr 12. doi: 10.3892/ijo.2016.3483.
    PubMed     Text format     Abstract available


  40. GALLARDO M, Calaf GM
    Curcumin and epithelial-mesenchymal transition in breast cancer cells transformed by low doses of radiation and estrogen.
    Int J Oncol. 2016 Apr 7. doi: 10.3892/ijo.2016.3477.
    PubMed     Text format     Abstract available


  41. QUISBERT-VALENZUELA EO, Calaf GM
    Apoptotic effect of noscapine in breast cancer cell lines.
    Int J Oncol. 2016 Apr 7. doi: 10.3892/ijo.2016.3476.
    PubMed     Text format     Abstract available


  42. DE BLASIO A, Di Fiore R, Morreale M, Carlisi D, et al
    Unusual roles of caspase-8 in triple-negative breast cancer cell line MDA-MB-231.
    Int J Oncol. 2016 Apr 6. doi: 10.3892/ijo.2016.3474.
    PubMed     Text format     Abstract available


  43. GUO Y, Lin D, Zhang M, Zhang X, et al
    CLDN6-induced apoptosis via regulating ASK1-p38/JNK signaling in breast cancer MCF-7 cells.
    Int J Oncol. 2016 Apr 1. doi: 10.3892/ijo.2016.3469.
    PubMed     Text format     Abstract available


    March 2016
  44. LI C, Jung S, Yang Y, Kim KI, et al
    Inhibitory role of TRIP-Br1 oncoprotein in hypoxia-induced apoptosis in breast cancer cell lines.
    Int J Oncol. 2016 Mar 24. doi: 10.3892/ijo.2016.3454.
    PubMed     Text format     Abstract available


  45. DO CANTO LM, Marian C, Willey S, Sidawy M, et al
    MicroRNA analysis of breast ductal fluid in breast cancer patients.
    Int J Oncol. 2016 Mar 10. doi: 10.3892/ijo.2016.3435.
    PubMed     Text format     Abstract available


  46. PAYAN I, McDonnell S, Torres HM, Steelant WF, et al
    FAK tyrosine 407 organized with integrin alphaVbeta5 in Hs578Ts(i)8 advanced triple-negative breast cancer cells.
    Int J Oncol. 2016 Mar 7. doi: 10.3892/ijo.2016.3422.
    PubMed     Text format     Abstract available


  47. MAHMOUD AM, Aboul-Soud MA, Han J, Al-Sheikh YA, et al
    Transcriptional profiling of breast cancer cells in response to mevinolin: Evidence of cell cycle arrest, DNA degradation and apoptosis.
    Int J Oncol. 2016 Mar 4. doi: 10.3892/ijo.2016.3418.
    PubMed     Text format     Abstract available


    February 2016
  48. OUYANG Q, Zhang L, Jiang Y, Ni X, et al
    The membrane complement regulatory protein CD59 promotes tumor growth and predicts poor prognosis in breast cancer.
    Int J Oncol. 2016 Feb 24. doi: 10.3892/ijo.2016.3408.
    PubMed     Text format     Abstract available


  49. LI X, Xiao R, Tembo K, Hao L, et al
    PEG10 promotes human breast cancer cell proliferation, migration and invasion.
    Int J Oncol. 2016 Feb 23. doi: 10.3892/ijo.2016.3406.
    PubMed     Text format     Abstract available


  50. HUA K, Jin J, Zhao J, Song J, et al
    miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Int J Oncol. 2016 Feb 22. doi: 10.3892/ijo.2016.3405.
    PubMed     Text format     Abstract available


  51. KRITSANAWONG S, Innajak S, Imoto M, Watanapokasin R, et al
    Antiproliferative and apoptosis induction of alpha-mangostin in T47D breast cancer cells.
    Int J Oncol. 2016 Feb 18. doi: 10.3892/ijo.2016.3399.
    PubMed     Text format     Abstract available


  52. MOHAMEDI Y, Fontanil T, Solares L, Garcia-Suarez O, et al
    Fibulin-5 downregulates Ki-67 and inhibits proliferation and invasion of breast cancer cells.
    Int J Oncol. 2016 Feb 17. doi: 10.3892/ijo.2016.3394.
    PubMed     Text format     Abstract available


  53. ANTONILLI M, Rahimi H, Visconti V, Napoletano C, et al
    Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial.
    Int J Oncol. 2016 Feb 8. doi: 10.3892/ijo.2016.3386.
    PubMed     Text format     Abstract available


    January 2016
  54. LIU Y, Zou T, Wang S, Chen H, et al
    Genistein-induced differentiation of breast cancer stem/progenitor cells through a paracrine mechanism.
    Int J Oncol. 2016 Jan 19. doi: 10.3892/ijo.2016.3351.
    PubMed     Text format     Abstract available


  55. KONG L, Guo S, Liu C, Zhao Y, et al
    Overexpression of SDF-1 activates the NF-kappaB pathway to induce epithelial to mesenchymal transition and cancer stem cell-like phenotypes of breast cancer cells.
    Int J Oncol. 2016 Jan 15. doi: 10.3892/ijo.2016.3343.
    PubMed     Text format     Abstract available


  56. OWEN S, Sanders AJ, Mason MD, Jiang WG, et al
    Importance of osteoprotegrin and receptor activator of nuclear factor kappaB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro.
    Int J Oncol. 2016 Jan 15. doi: 10.3892/ijo.2016.3339.
    PubMed     Text format     Abstract available


  57. XU L, Zhang L, Hu C, Liang S, et al
    WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
    Int J Oncol. 2016 Jan 13. doi: 10.3892/ijo.2016.3337.
    PubMed     Text format     Abstract available


  58. FANG Y, Zhang Q, Wang X, Yang X, et al
    Quantitative phosphoproteomics reveals genistein as a modulator of cell cycle and DNA damage response pathways in triple-negative breast cancer cells.
    Int J Oncol. 2016 Jan 11. doi: 10.3892/ijo.2016.3327.
    PubMed     Text format     Abstract available


  59. LI W, Liu C, Zhao C, Zhai L, et al
    Downregulation of beta3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets1 network in triple-negative breast cancer.
    Int J Oncol. 2016 Jan 5. doi: 10.3892/ijo.2016.3319.
    PubMed     Text format     Abstract available


  60. MOHAMMED FH, Khajah MA, Yang M, Brackenbury WJ, et al
    Blockade of voltage-gated sodium channels inhibits invasion of endocrine-resistant breast cancer cells.
    Int J Oncol. 2016;48:73-83.
    PubMed     Text format     Abstract available


    December 2015
  61. PONCE-CUSI R, Calaf GM
    Apoptotic activity of 5-fluorouracil in breast cancer cells transformed by low doses of ionizing alpha-particle radiation.
    Int J Oncol. 2015 Dec 18. doi: 10.3892/ijo.2015.3298.
    PubMed     Text format     Abstract available


  62. YAN LX, Liu YH, Xiang JW, Wu QN, et al
    PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
    Int J Oncol. 2015 Dec 10. doi: 10.3892/ijo.2015.3287.
    PubMed     Text format     Abstract available


  63. KANG DY, Darvin P, Yoo YB, Joung YH, et al
    Methylsulfonylmethane inhibits HER2 expression through STAT5b in breast cancer cells.
    Int J Oncol. 2015 Dec 7. doi: 10.3892/ijo.2015.3277.
    PubMed     Text format     Abstract available


    November 2015
  64. CHU CY, Jin YT, Zhang W, Yu J, et al
    CA IX is upregulated in CoCl2-induced hypoxia and associated with cell invasive potential and a poor prognosis of breast cancer.
    Int J Oncol. 2015 Nov 19. doi: 10.3892/ijo.2015.3253.
    PubMed     Text format     Abstract available


  65. TAURIN S, Nimick M, Larsen L, Rosengren RJ, et al
    A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines.
    Int J Oncol. 2015 Nov 19. doi: 10.3892/ijo.2015.3252.
    PubMed     Text format     Abstract available


  66. ZHANG C, Liu K, Li T, Fang J, et al
    miR-21: A gene of dual regulation in breast cancer.
    Int J Oncol. 2015 Nov 5. doi: 10.3892/ijo.2015.3232.
    PubMed     Text format     Abstract available


    October 2015
  67. FOROOTAN SS, Butler JM, Gardener D, Baird AE, et al
    Transcriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with major therapeutic implications.
    Int J Oncol. 2015 Oct 30. doi: 10.3892/ijo.2015.3222.
    PubMed     Text format     Abstract available


  68. GAO C, Hong M, Geng J, Zhou H, et al
    Characterization of PI (breast cancer cell special peptide) in MDA-MB-231 breast cancer cells and its potential therapeutic applications.
    Int J Oncol. 2015;47:1371-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: